Ole Lemming

1.4k citations

27 papers · 1.1k indexed · h-index 16

Impact in

Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Attention Deficit Hyperactivity Disorder
Pharmacology top 2%
- Treatment of Major Depression

Papers in ⓘ

Psychiatry and Mental health 19
- Schizophrenia research and treatment 9
- Bipolar Disorder and Treatment 6
- Electroconvulsive Therapy Studies 6
- Dementia and Cognitive Impairment Research 5
- Attention Deficit Hyperactivity Disorder 4
Pharmacology 14
- Treatment of Major Depression 12

Co-authors: Alan Wade (2 shared papers)Dan J. Stein (2 shared papers)Siegfried Kasper (2 shared papers)Stuart Montgomery (1 shared paper)Per Bech (2 shared papers)David Wilkinson (2 shared papers)José Luís Molinuevo (2 shared papers)Emmanuelle Weiller (1 shared paper)
Journals: International Clinical Psychopharmacology (5 papers)European Neuropsychopharmacology (3 papers)Alzheimer s & Dementia (2 papers)Journal of Child and Adolescent Psychopharmacology (2 papers)Journal of Clinical Psychopharmacology (2 papers)
Partner nations: Denmark United Kingdom United States

In The Last Decade

Ole Lemming

27 papers receiving 993 citations

Peers

Countries citing papers authored by Ole Lemming

Since Specialization

Citations

This map shows the geographic impact of Ole Lemming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Lemming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Lemming more than expected).

Fields of papers citing papers by Ole Lemming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Lemming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Lemming. The network helps show where Ole Lemming may publish in the future.

Co-authors

The 25 scholars most cited alongside Ole Lemming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ole Lemming Line = papers co-authored together Ole Lemming links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Escitalopram 10???mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care International Clinical Psychopharmacology ·Alan Wade, Ole Lemming, K. Bang Hedegaard	2002	196
2	Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder International Clinical Psychopharmacology ·Stuart Montgomery, Siegfried Kasper, Dan J. Stein, K. Bang Hedegaard, Ole Lemming	2001	136
3	Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy Alzheimer s Research & Therapy ·Alireza Atri, José Luís Molinuevo, Ole Lemming, Yvonne Wirth, Irena Pulte, David Wilkinson	2013	95
4	A Randomized, Double-blind, Placebo-controlled Study of Citalopram in Adolescents With Major Depressive Disorder Journal of Clinical Psychopharmacology ·Anne‐Liis von Knorring, Gunilla Olsson, Per Hove Thomsen, Ole Lemming, Agnes Hultén	2006	83
5	PANSS‐6: a brief rating scale for the measurement of severity in schizophrenia Acta Psychiatrica Scandinavica ·Søren Dinesen Østergaard, Ole Lemming, Ole Mors, Christoph U. Correll, Per Bech	2015	79
6	Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice International Clinical Psychopharmacology ·Michel Patris, J. M. Bouchard, Thierry Bougerol, J-F. Charbonnier, J-F. Chevalier, G. Clerc, C. Cyran, P. Van Amerongen, Ole Lemming, H. E. Høpfner Petersen	1996	75
7	Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder American Journal of Geriatric Psychiatry ·Philip Gorwood, Emmanuelle Weiller, Ole Lemming, Cornelius Katona	2007	69
8	Escitalopram prevents relapse of obsessive-compulsive disorder European Neuropsychopharmacology ·Naomi Fineberg, Brigitte Tonnoir, Ole Lemming, Dan J. Stein	2007	56
9	A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease International Psychogeriatrics ·Nathan Herrmann, Serge Gauthier, Neli Boneva, Ole Lemming	2013	43
10	The Validity of the Different Versions of the Hamilton Depression Scale in Separating Remission Rates of Placebo and Antidepressants in Clinical Trials of Major Depression Journal of Clinical Psychopharmacology ·Phillip Raphael Kyle, Ole Lemming, Nina Timmerby, Susan Søndergaard, Kate Andreasson, Per Bech	2016	38
11	Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial Journal of Alzheimer s Disease ·David Wilkinson, (unknown), Nick C. Fox, Frederik Barkhof, Ravinder K. Phul, Ole Lemming, Philip Scheltens	2012	34
12	Citalopram and Fluoxetine in Major Depression Clinical Drug Investigation ·Thierry Bougerol, Jean‐Claude Scotto, Michel Patris, Nathalie Strub, Ole Lemming, H. E. Høpfner Petersen	1997	25
13	Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials International Journal of Bipolar Disorders ·Trisha Suppes, Jonas Eberhard, Ole Lemming, Allan H. Young, Roger S. McIntyre	2017	22
14	Escitalopram in the Long-Term Treatment of Major Depressive Disorder in Elderly Patients Neuropsychobiology ·Siegfried Kasper, Ole Lemming, Hans de Swart	2006	16
15	A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders Journal of Child and Adolescent Psychopharmacology ·Robert L. Findling, Adelaide S. Robb, Melissa P. DelBello, Michael Huß, Nora McNamara, Elias Sarkis, Russell E. Scheffer, Lis H. Poulsen, Grace Chen, Ole Lemming, Philippe Auby	2017	15
16	Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients Journal of Child and Adolescent Psychopharmacology ·Robert L. Findling, Adelaide S. Robb, Melissa P. DelBello, Michael Huß, Nora McNamara, Elias Sarkis, Russell E. Scheffer, Lis H. Poulsen, Grace Chen, Ole Lemming, Johan Areberg, Philippe Auby	2017	15
17	Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension Schizophrenia Research ·John M. Kane, Bruce J. Kinon, Carlos Forray, Pedro Such, Aurélia Mittoux, Ole Lemming, P. Hertel, Oliver Howes	2022	10
18	A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia European Neuropsychopharmacology ·Andreas Meyer‐Lindenberg, Jacob Nielsen, Pedro Such, Ole Lemming, János Zámbori, R. Buller, Christoph von der Goltz	2022	9
19	Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice International Clinical Psychopharmacology ·Michel Patris, J-M. Bouchard, T Bougerol, J-F. Charbonnier, J-F. Chevalier, G. Clerc, C. Cyran, P. Van Amerongen, Ole Lemming, H. E. Høpfner Petersen	1996	8
20	Measuring Therapeutic Efficacy in Patients with Alzheimer’s Disease: Role of Instruments Dementia and Geriatric Cognitive Disorders ·Matthias W. Riepe, Wolfgang Janetzky, Ole Lemming	2011	7

About Ole Lemming

Ole Lemming is a scholar working on Psychiatry and Mental health, Pharmacology, Experimental and Cognitive Psychology, Clinical Psychology and Neurology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Treatment of Major Depression (12 papers), Schizophrenia research and treatment (9 papers), Bipolar Disorder and Treatment (6 papers), Electroconvulsive Therapy Studies (6 papers), Dementia and Cognitive Impairment Research (5 papers), Attention Deficit Hyperactivity Disorder (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Mental Health Research Topics (3 papers). The work is most often cited by research in Psychiatry and Mental health (464 citations), Pharmacology (486 citations), Biological Psychiatry (70 citations), Experimental and Cognitive Psychology (342 citations) and Clinical Psychology (301 citations). Ole Lemming has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Alan Wade, Dan J. Stein, Siegfried Kasper, Stuart Montgomery, Per Bech, David Wilkinson, José Luís Molinuevo, Emmanuelle Weiller, Anne‐Liis von Knorring and Per Hove Thomsen. Their work appears in journals such as International Clinical Psychopharmacology, European Neuropsychopharmacology, Alzheimer s & Dementia, Journal of Child and Adolescent Psychopharmacology and Journal of Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact